Hyatt Regency Barcelona Tower | Barcelona, Spain
Booth #8
We look forward to meeting you at EBF in Barcelona.
Request a meeting with our team to learn how we help our clients advance their drug modality.
Author: Robert Nelson, PhD, on behalf of EBF – Scientific Officer
Wednesday, November 15, 2023
9:30 – 10:30 a.m.
Presenter: Shashank Gorityala, PhD - Associate Director
Wednesday, November 15, 2023
12:30 –12:50 p.m.
Author: Christopher Tiedje, PhD - Principal Investigator
Thursday, November 16, 2023
9:40 – 10:00 a.m.
Presenter: Amanda Hays, PhD on behalf of AAPS - Scientific Officer
Thursday, November 16, 2023
11:20 – 11:40 a.m.
Presenter: Ben Nie, PhD - Scientist III
Thursday, November 16, 2023
11:40 – 12:00 p.m.
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies. The goal was to create a platform for discussions around science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. Until 2010, EBF membership was limited to pharmaceutical research and development companies with bioanalytical activities in Europe. From 2011 onwards, the EBF welcomed CROs involved in bioanalytical activities in Europe. Since 2010, the EBF became a non-profit organization (vzw) established pursuant to the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations. Currently, the EBF counts 75 members (June 2022).
Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form, and an expert will reach out to schedule a meeting with you onsite.
Speak with our scientific experts onsite to discuss your project.
© Copyright 2024 BioAgilytix Labs. All rights reserved.
